20 research outputs found
Research Article (New England Journal of Medicine) A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults
Background: Streptococcus pneumoniae is a leading and serious coinfection in adults with human immunodeficiency virus (HIV) infection, particularly in Africa. Prevention of this disease by vaccination with the current 23-valent polysaccharide vaccine is suboptimal. Protein conjugate vaccines offer a further option for protection, but data on their clinical efficacy in adults are needed.Methods: In this double-blind, randomized, placebo-controlled clinical efficacy trial, we studied the efficacy of a 7-valent conjugate pneumococcal vaccine in predominantly HIV-infected Malawian adolescents and adults who had recovered from documented invasive pneumococcal disease. Two doses of vaccine were given 4 weeks apart. The primary end point was a further episode of pneumococcal infection caused by vaccine serotypes or serotype 6A.Results: From February 2003 through October 2007, we followed 496 patients (of whom 44% were male and 88% were HIV-seropositive) for 798 person-years of observation. There were 67 episodes of pneumococcal disease in 52 patients, all in the HIV-infected subgroup. In 24 patients, there were 19 episodes that were caused by vaccine serotypes and 5 episodes that were caused by the 6A serotype. Of these episodes, 5 occurred in the vaccine group and 19 in the placebo group, for a vaccine efficacy of 74% (95% confidence interval [CI], 30 to 90). There were 73 deaths from any cause in the vaccine group and 63 in the placebo group (hazard ratio in the vaccine group, 1.18; 95% CI, 0.84 to 1.66). The number of serious adverse events within 14 days after vaccination was significantly lower in the vaccine group than in the placebo group (3 vs. 17, P = 0.002), and the number of minor adverse events was significantly higher in the vaccine group (41 vs. 13, P = 0.003).Conclusions: The 7-valent pneumococcal conjugate vaccine protected HIV-infected adults from recurrent pneumococcal infection caused by vaccine serotypes or serotype 6A. (Current Controlled Trials number, ISRCTN54494731.
Recommended from our members
Measuring Regional Policy Change and Pro-Poor Health Policy Success: A PRARI Toolkit of Indicators for the Southern African Development Community (SADC)
PRARI is a social development research project that looks at world-regional social governance, politics, and policy. PRARI brings together an international team of researchers studying the scope for enhancing the effectiveness of the contributions of Southern regional organisations to poverty reduction. It receives funding from the ESRC
Who is excluded and how? An analysis of community spaces for maternal and child health in Pakistan
Critical agency and development: applying Freire and Sen to ICT4D in Zambia and Brazil
This paper draws upon critical theories and the capability approach. It argues for a conceptualization of development as a process designed to enable people to free themselves from structural disadvantage. Amartya Sen has argued that people’s “critical-agency” to question and reject unjust social norms is “pivotal” to human development and important for tackling inequalities of any kind. Freire’s critical pedagogy, and critical feminism, go further by providing disadvantaged people with the practical means to do this; to identify the structural root causes of unjust social norms and the critical-agency to challenge and change them. Two empirical case studies of ICT4D are presented, from Zambia and Brazil, which draw upon these critical approaches but use them in different ways. The paper argues that ICT4D must go beyond addressing people’s immediate practical needs for access to ICT tools and skills, to also address their strategic interest in identifying and tackling the root causes of disadvantage
Delayed acquisition of Plasmodium falciparum antigen-specific CD4+ T cell responses in HIV-exposed uninfected Malawian children receiving daily cotrimoxazole prophylaxis
Review of sustainable solar powered water supply system design approach by Water Mission Malawi
Abstract
Water Mission's extensive experience in designing, constructing and supporting solar-powered pumping solutions demonstrates the technological viability and cost effectiveness for delivering safe water to people, particularly in rural areas. Water Mission follows a unique design approach that uses conventional but relatively unique engineering specifications in terms of hydraulics, power requirement, water treatment and distribution, having tested them in different geographical environments. Water Mission incorporates a community-managed sustainability model into the design to ensure a longer life span for the project by promoting a well-defined maintenance and sustainability plan. This approach was applied to ten projects in 2015 in Kasungu, Lilongwe and Blantyre districts where installation, monitoring and evaluation were done and subjected to Water Mission's standards for qualification to hand them over to the beneficiary communities at the end of one year post installation. The paper is a review and discussion of the steps that Water Mission follows in its design process to come up with a sustainable project with solar energy. The paper also illustrates the non-compromise stand by Water Mission when it comes to the hand-over criteria for its projects by following and respecting the results of the prescribed evaluation test. It highlights detailed advantages and disadvantages of the design approach and presents recommendations. It is concluded that the approach can be replicated elsewhere in Malawi as a solution to water supply.</jats:p
